vs
Amneal Pharmaceuticals, Inc.（AMRX）与REPUBLIC AIRWAYS HOLDINGS INC.（RJET）财务数据对比。点击上方公司名可切换其他公司
REPUBLIC AIRWAYS HOLDINGS INC.的季度营收约是Amneal Pharmaceuticals, Inc.的1.5倍（$1.1B vs $722.5M），过去两年REPUBLIC AIRWAYS HOLDINGS INC.的营收复合增速更高（3.9% vs 1.5%）
Amneal Pharmaceuticals是一家美国上市制药企业，核心业务涵盖仿制药及专科药物的研发、生产与分销，总部位于新泽西州布里奇沃特，是美国规模最大的仿制药生产商之一。
共和航空控股是一家总部位于美国印第安纳州印第安纳波利斯的航空控股企业，旗下拥有梅萨航空与共和航空两家支线航空公司。两家公司合计运营的巴航工业E170与E175客机规模为全球第一，公司多数股权由与其签订合作协议的美国航空、达美航空、联合航空这几家干线航司持有。
AMRX vs RJET — 直观对比
营收规模更大
RJET
是对方的1.5倍
$722.5M
两年增速更快
RJET
近两年复合增速
1.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $722.5M | $1.1B |
| 净利润 | $78.0M | — |
| 毛利率 | 44.3% | — |
| 营业利润率 | — | 22.0% |
| 净利率 | 10.8% | — |
| 营收同比 | 3.9% | — |
| 净利润同比 | 217.0% | — |
| 每股收益（稀释后） | $0.19 | $3.13 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRXRJET
| Q1 26 | $722.5M | — | ||
| Q4 25 | $814.3M | $1.1B | ||
| Q3 25 | $784.5M | $90.7M | ||
| Q2 25 | $724.5M | $92.8M | ||
| Q1 25 | $695.4M | $94.7M | ||
| Q4 24 | $730.5M | $808.3M | ||
| Q3 24 | $702.5M | — | ||
| Q2 24 | $701.8M | $110.8M |
净利润AMRXRJET
| Q1 26 | $78.0M | — | ||
| Q4 25 | $35.1M | — | ||
| Q3 25 | $2.4M | $-14.1M | ||
| Q2 25 | $22.4M | $20.9M | ||
| Q1 25 | $12.2M | $-58.6M | ||
| Q4 24 | $-31.1M | $97.8M | ||
| Q3 24 | $-156.0K | — | ||
| Q2 24 | $6.0M | $-19.9M |
毛利率AMRXRJET
| Q1 26 | 44.3% | — | ||
| Q4 25 | 36.5% | — | ||
| Q3 25 | 34.9% | — | ||
| Q2 25 | 39.5% | — | ||
| Q1 25 | 36.8% | — | ||
| Q4 24 | 36.0% | — | ||
| Q3 24 | 38.4% | — | ||
| Q2 24 | 35.6% | — |
营业利润率AMRXRJET
| Q1 26 | — | — | ||
| Q4 25 | 13.8% | 22.0% | ||
| Q3 25 | 9.0% | -10.1% | ||
| Q2 25 | 15.4% | -0.2% | ||
| Q1 25 | 14.4% | -60.4% | ||
| Q4 24 | 10.4% | 18.7% | ||
| Q3 24 | 12.6% | — | ||
| Q2 24 | 13.6% | -8.1% |
净利率AMRXRJET
| Q1 26 | 10.8% | — | ||
| Q4 25 | 4.3% | — | ||
| Q3 25 | 0.3% | -15.6% | ||
| Q2 25 | 3.1% | 22.5% | ||
| Q1 25 | 1.8% | -61.9% | ||
| Q4 24 | -4.3% | 12.1% | ||
| Q3 24 | -0.0% | — | ||
| Q2 24 | 0.9% | -18.0% |
每股收益（稀释后）AMRXRJET
| Q1 26 | $0.19 | — | ||
| Q4 25 | $0.10 | $3.13 | ||
| Q3 25 | $0.01 | $-0.34 | ||
| Q2 25 | $0.07 | $0.50 | ||
| Q1 25 | $0.04 | $-1.42 | ||
| Q4 24 | $-0.10 | $2.42 | ||
| Q3 24 | $0.00 | — | ||
| Q2 24 | $0.02 | $-0.48 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $296.5M |
| 总债务越低越好 | — | $882.9M |
| 股东权益账面价值 | — | $1.3B |
| 总资产 | — | $3.3B |
| 负债/权益比越低杠杆越低 | — | 0.66× |
8季度趋势，按日历期对齐
现金及短期投资AMRXRJET
| Q1 26 | — | — | ||
| Q4 25 | $282.0M | $296.5M | ||
| Q3 25 | $201.2M | $38.7M | ||
| Q2 25 | $71.5M | $42.5M | ||
| Q1 25 | $59.2M | $54.1M | ||
| Q4 24 | $110.6M | $302.0M | ||
| Q3 24 | $74.0M | — | ||
| Q2 24 | $43.8M | $16.3M |
总债务AMRXRJET
| Q1 26 | — | — | ||
| Q4 25 | $2.6B | $882.9M | ||
| Q3 25 | $2.6B | $27.0M | ||
| Q2 25 | $2.2B | $28.2M | ||
| Q1 25 | $2.2B | $31.7M | ||
| Q4 24 | $2.4B | $752.2M | ||
| Q3 24 | $2.4B | — | ||
| Q2 24 | $2.4B | $287.7M |
股东权益AMRXRJET
| Q1 26 | — | — | ||
| Q4 25 | $-70.8M | $1.3B | ||
| Q3 25 | $-109.5M | $-52.6M | ||
| Q2 25 | $-112.1M | $-38.7M | ||
| Q1 25 | $-131.7M | $-59.8M | ||
| Q4 24 | $-109.3M | $1.1B | ||
| Q3 24 | $-93.4M | — | ||
| Q2 24 | $-57.5M | $134.9M |
总资产AMRXRJET
| Q1 26 | — | — | ||
| Q4 25 | $3.7B | $3.3B | ||
| Q3 25 | $3.6B | $158.9M | ||
| Q2 25 | $3.4B | $178.6M | ||
| Q1 25 | $3.4B | $215.0M | ||
| Q4 24 | $3.5B | $2.8B | ||
| Q3 24 | $3.5B | — | ||
| Q2 24 | $3.5B | $664.4M |
负债/权益比AMRXRJET
| Q1 26 | — | — | ||
| Q4 25 | — | 0.66× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.68× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | 2.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRX
| Affordable Medicines net | $423.0M | 59% |
| AvKARE net | $166.0M | 23% |
| Specialty net | $133.0M | 18% |
RJET
| United Airlines | $517.5M | 48% |
| Delta Air Lines | $409.7M | 38% |
| Other | $49.9M | 5% |
| Republic Airways Holdings Inc. | $42.2M | 4% |
| Other Airlines | $25.7M | 2% |
| LIFT Academy | $23.2M | 2% |
